EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

J Lupberger, M B Zeisel, F Xiao, C Thumann, L zona, C Davis, C J Mee, M Turek, S Gorke, C Royer, B Fischer, M N Zahid, D Lavillette, J Fresquet, F L Cosset, S M Rothenberg, T Pietschmann, A H Patel, P Pessaux, M Doffoel, W Raffelsberger, O Poch, J A McKeating, L Brino, T F Baumert